20 Biggest Mid-Day Losers For Thursday

Adeptus Health Inc ADPT shares dipped 43.4 percent to $3.71 after dropping 2.96 percent on Wednesday.
Omega Protein Corporation OME dropped 20.2 percent to $21.00 after the company posted weak Q4 earnings.
Puma Biotechnology Inc PBYI shares declined 19.3 percent to $30.70. Puma Biotechnology reported Q4 adjusted loss of $1.22 per share. Puma Biotechnology also reported the publication of abstracts on neratinib for the AACR Annual Meeting 2017
PTC Therapeutics, Inc. PTCT shares tumbled 15.8 percent to $11.10 after the company disclosed that Ataluren Confirmatory Trial missed primary and secondary endpoints.
Endeavour Silver Corp EXK fell 14.4 percent to $3.76. Endeavour Silver reported a Q4 loss of $5.2 million.
Vectrus Inc VEC dropped 12.7 percent to $21.62 on weak quarterly earnings.
Greif, Inc. GEF shares slipped 12.7 percent to $52.63 after the company posted downbeat Q1 earnings.
ANI Pharmaceuticals Inc ANIP shares declined 12.4 percent to $52.39. ANI Pharmaceuticals reported a Q4 loss of $1.1 million on revenue of $38.2 million.
AXT Inc AXTI dropped 11.6 percent to $6.63. AXT priced 4.6 million shares at $6.50 per share.
Health Insurance Innovations Inc HIIQ shares fell 11.5 percent to $15.80. Health Insurance Innovations reported a Q4 loss of $200,000.
Ashford Hospitality Prime Inc AHP shares dropped 10.1 percent to $11.60. Ashford Prime reported a 1.15 million share offering of common stock and announced plans to acquire Hotel Yountville for $96.5 million.
Ares Management LP ARES declined 10 percent to $19.80. Ares Management reported the launch of 7.5 million unit secondary offering.
HTG Molecular Diagnostics Inc HTGM shares slipped 9.7 percent to $2.86 after rising 16.12 percent on Wednesday.
Opko Health Inc. OPK shares dropped 9.7 percent to $7.55. OPKO Health reported a Q4 loss of $0.04 per share on revenue of $275.5 million.
TICC Capital Corp. TICC fell 9.5 percent to $7.14. TICC reported net investment income of $0.14 per share for the quarter ended December 31, 2016.
Kratos Defense & Security Solutions, Inc KTOS declined 8.2 percent to $7.37 after reporting a proposed public offering of common stock.
Stage Stores Inc SSI declined 6 percent to $2.18 after the company reported weaker-than-expected earnings for its fourth quarter and issued a downbeat forecast for FY 2017.
Juno Therapeutics Inc JUNO slipped 4.8 percent to $24.10. Juno Therapeutics reported a Q4 loss of $0.51 per share on revenue of $21.153 million. Juno also announced plans to end development of its cancer drug.
Kite Pharma Inc KITE fell 4.8 percent to $75.79. Kite reported commencement of 4.75 million share offering. Citigroup downgraded Kite Pharma from Buy to Neutral.
Anheuser Busch Inbev NV (ADR) BUD fell 2.7 percent to $106.99 on weak quarterly earnings. Bank of America downgraded Anheuser-Busch Inbev from Buy to Neutral.

Market News and Data brought to you by Benzinga APIs

Comments

Analyst Calendar

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga